A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...

Two groups have filed a lawsuit over an executive order by West Virginia's governor granting religious exemptions from ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

World Health Organization (WHO) member countries adopted a new treaty on May 20, 2025, to improve international coordination ...

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated ...

Low uptake may reflect barriers—misinformation, access or shifting insurance coverage—not simply waning need.

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

The much-anticipated report calls for increased scrutiny of the vaccine schedule and describes the nation’s children as overmedicated.